'Multi-target' immune therapy improves outcomes of severe lupus nephritis

A new treatment using a combination of drugs targeting different parts of the immune system improves the recovery rate for patients with severe lupus involving the kidneys, according to a report in the October Journal of the American Society of Nephrology (JASN).

Read the whole article on Physorg

More from Physorg